Evidence map›Paper›PMID 35799783›Full record

ReviewFrontiers in immunology2022

Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?

Sabrina N Copsel, Dietlinde Wolf, Brent Pfeiffer, Henry Barreras, Victor L Perez, Robert B Levy

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sabrina N CopselDepartment of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL, United States.
Dietlinde WolfSylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL, United States.
Brent PfeifferDepartment of Pediatrics, University of Miami School of Medicine, Miami, FL, United States.
Henry BarrerasDepartment of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL, United States.
Victor L PerezFoster Center for Ocular Immunology, Duke Eye Center, Duke University, Durham, NC, United States.
Robert B LevyDepartment of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL, United States.

Funding

Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephen D. Nimer · 2019 to 2026
$24.1M
Immune Mechanisms in Ocular Graft versus Host DiseaseR01EY024484 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEVY, ROBERT BENJAMIN, PEREZ, VICTOR L · 2014 to 2025
$5.1M
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplantsR01EY030283 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Robert Benjamin Levy, Victor L Perez · 2020 to 2026
$3.1M
Application of TNFRSF25 agonists for prophylaxis and treatment of graft versus host diseaseR41AI149916 · NIAID · PELICAN THERAPEUTICS, INC. · PI SEAVEY, MATTHEW · 2020 to 2020
$225k
NCI NIH HHS P30 CA240139NEI NIH HHS R01 EY024484NEI NIH HHS R01 EY030283NIAID NIH HHS R41 AI149916
6 · The paper itself

Abstract

Human and mouse CD4

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAnimalsImmune ToleranceMiceSelf ToleranceT-Lymphocytes, RegulatoryGvHDHSCT = hematopoietic stem cell transplantrecipient tregstreatmentTregs

Identifiers

PMID35799783
PMCPMC9253768

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.